PEDIATRICS Vol. 95 No. 3 March 1995, pp. 443-451
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation

Health Supervision for Children With Achondroplasia

Committee on Genetics

This set of guidelines is designed to assist the pediatrician in caring for children with achondroplasia confirmed by radiographs and physical features. Although pediatricians usually first see children with achondroplasia during infancy, occasionally they are called on to advise the pregnant woman who has been informed of the prenatal diagnosis of achondroplasia or asked to examine the newborn to help establish the diagnosis. Therefore, these guidelines offer advice for these situations as well.

Achondroplasia is the most common form of disproportionate short stature.1 The diagnosis is based on very specific features on the radiographs, which include a contracted base of the skull, a square shape to the pelvis with a small sacrosciatic notch, short pedicles of the vertebrae, rhizomelic (proximal) shortening of the long bones, trident hands, a normal length trunk, proximal femoral radiolucency, and, by mid-childhood, a characteristic chevron shape of the distal femoral epiphysis. Hypochondroplasia and thanatophoric dysplasia are part of the differential diagnosis, but achondroplasia can be distinguished from these because the changes in hypochondroplasia are milder and the changes in thanatophoric dysplasia are much more severe and invariably lethal. Achondroplasia is an autosomal dominant disorder, but approximately 75% of cases represent new dominant mutations. The gene for achondroplasia has recently been found. Achondroplasia is due to a change in the genetic information for fibroblast growth factor receptor 3.2,3 Almost all of the mutations have been found to occur in exactly the same spot. Now that the gene has been found and the mutation known, potential therapies and diagnostic methodologies are likely to be developed.


The following policy statement is a revision:

Health Supervision for Children With Achondroplasia
, , and
Pediatrics 116: 771-783. [Full Text]



This article has been cited by other articles:


Home page
 Arch Otolaryngol Head Neck SurgHome page
W. O. Collins and S. S. Choi
Otolaryngologic Manifestations of Achondroplasia
Arch Otolaryngol Head Neck Surg, March 1, 2007; 133(3): 237 - 244.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
T. L. Trotter, J. G. Hall, and and the Committee on Genetics
Health Supervision for Children With Achondroplasia
Pediatrics, September 1, 2005; 116(3): 771 - 783.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
R. C Tasker, I. Dundas, A. Laverty, M. Fletcher, R. Lane, and J. Stocks
Distinct patterns of respiratory difficulty in young children with achondroplasia: a clinical, sleep, and lung function study
Arch. Dis. Child., August 1, 1998; 79(2): 99 - 108.
[Abstract] [Full Text]